Trial Profile

A Phase 2, Open-label Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tenapanor (Primary)
Indications Hyperphosphataemia
Focus Therapeutic Use
Sponsors Kyowa Kirin

Most Recent Events

12 Oct 2020 According to an Ardelyx media release, data from this trial will be presented at Kidney Week 2020, the American Society of Nephrology's (ASN) Annual Meeting
15 Jun 2020 Results presented in an Ardelyx media release.
15 Jun 2020 Results from the trial were presented at the European Renal Association-European Dialysis and Transplant Association annual meeting (ERA-EDTA 2020).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com